Abingworth Investor

Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors.
Supporting its portfolio companies with a team of 27 at offices in London, Menlo Park, and Boston, Abingworth has invested in 142 life science companies, completed 60 IPOs and 40 mergers and acquisitions.
Industry: Regenerative Medicine
Headquarters: London, England, United Kingdom
Founded Date: 1973
Employees Number: 11-50
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity
Number Of Exits: 61

Visit Website
info@abingworth.com
@abingworthbio
Register and Claim Ownership